
News|Articles|January 1, 2003
Incorporating an ethical template into pharmacy benefit decision-making
If asked, could you present the underlying rationale for your pharmacy benefit coverage decisions? When considered from the consumer or employee perspective, why should they consider the payors or providers of their drug benefit legitimate decision-makers in limiting their healthcare policies?
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers highlight DR-70 as a possible biomarker for early bladder cancer detection
2
COVID-19 vaccines could help tumors respond better to immune checkpoint inhibitors
3
FDA approves Poherdy, first biosimilar of Perjeta, to treat HER-positive breast cancer
4
Cogent Biosciences’ phase 3 PEAK trial marks an advance in the treatment of gastrointestinal stromal tumors.
5


















































